Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.
Dailey
George
G
Scripps Clinic, 10666 North Torrey Pines Rd., La Jolla, CA 92037, USA. dailey.george@scrippshealth.org
Rosenstock
Julio
J
Moses
Robert G
RG
Ways
Kirk
K
D000368:Aged; D001786:Blood Glucose / Q000032:analysis / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis* / Q000187:drug effects; D006801:Humans; D007003:Hypoglycemia / Q000175:diagnosis / Q000453:epidemiology; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D007336:Insulin, Isophane / Q000008:administration & dosage*; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D011336:Probability; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016037:Single-Blind Method; D016896:Treatment Outcome
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin; D007336:Insulin, Isophane; C479079:insulin glulisine